Difference between revisions of "Hepatorenal syndrome"

(EvaluationDeepika D et al. Hepatorenal Syndrome Workup. Dec 27, 2015. http://emedicine.medscape.com/article/178208-workup#showall)
(Management)
 
(4 intermediate revisions by 4 users not shown)
Line 2: Line 2:
 
*[[Acute renal failure]] in patient with normal kidneys in presence of acute/chronic hepatic failure  
 
*[[Acute renal failure]] in patient with normal kidneys in presence of acute/chronic hepatic failure  
 
*Often heralded by the presence of [[SBP]]
 
*Often heralded by the presence of [[SBP]]
*Cause is unknown
+
* Arterial vasodilatation in the splanchnic circulation, which is triggered by portal hypertension
 +
*Diagnosis of exclusion
  
 
==Clinical Features==
 
==Clinical Features==
Line 53: Line 54:
 
*Other:
 
*Other:
 
**[[TIPS]], [[hemodialysis|renal replacement therapy]]
 
**[[TIPS]], [[hemodialysis|renal replacement therapy]]
 +
**Avoid diuretics and benzodiazepines
 +
**Discuss giving octreotide and/or midodrine with admitting physician
  
 
==Disposition==
 
==Disposition==
Line 66: Line 69:
 
<references/>  
 
<references/>  
 
[[Category:GI]]
 
[[Category:GI]]
 +
[[Category:Renal]]

Latest revision as of 12:38, 24 April 2021

Background

  • Acute renal failure in patient with normal kidneys in presence of acute/chronic hepatic failure
  • Often heralded by the presence of SBP
  • Arterial vasodilatation in the splanchnic circulation, which is triggered by portal hypertension
  • Diagnosis of exclusion

Clinical Features

  • Type 1
    • Doubling of serum creatinine over a 2-week period
    • Progressive oliguria
  • Type 2
    • Gradual impairment in renal function (that may not advance beyond moderate)

Differential Diagnosis

Evaluation[1]

  • Abdominal US
  • Diagnostic paracentesis
  • Ascites fluid cultures and analysis
  • Labs:
    • CBC with diff
    • BMP
    • LFTs
    • Blood cultures
    • Urinalysis
    • Urine electrolytes and osmolality
    • Consultants: alpha-fetoprotein, cryoglobulins
  • All major criteria must be met for diagnosis for both HRS types 1 and 2:
    • Serum creatinine >1.5mg/dL
    • No improvement in renal function after halting diuretics AND admin of 1.5 L of plasma expander
    • Proteinuria <500mg/d
    • No ultrasound evidence of obstructive uropathy or renal parenchymal disease
    • Absence of shock, bacterial infection, hypovolemia, nephrotoxic meds
  • Supporting criteria not required for diagnosis:
    • Uop <500 cc/day
    • Urine sodium <10 mEq/L
    • Urine osmolality > plasma osmolality
    • Urine RBC <50 cells/hpf
    • Serum sodium <130 mEq/L

Management

  • Vasopressors
    • Terlipressin: 0.5-1mg q 4-6 IV us 5-15d
    • Norepinephrine: 0.5-3mg/hr to increase MAP by 10mmHg
    • Midodrine: 7.5mg PO tid with Octreotide 100mcg sq
  • Albumin: 1-1.5g/kg with one of above
  • Other:

Disposition

  • 1-month survival: 50%
  • 6-month survival: 20%
  • Should be evaluated at liver transplant center
  • May require TIPS, vasoconstrictors as bridge to transplant

See Also

References

  • NEJM vol 361 no 13 P. Gines
  1. Deepika D et al. Hepatorenal Syndrome Workup. Dec 27, 2015. http://emedicine.medscape.com/article/178208-workup#showall